Seres Therapeutics Inc

Healthcare · Biotechnology

3.50$ -2.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Seres Therapeutics Inc (MCRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 102 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MCRB
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	298	273	245	216	212	190	159	133	109	120	107	146	124	132	111	101	356	343	306	270	396	355	320	273	312	349	270	406	368	359	341	322	179	140	164	144	143	138	118	102
Current Assets	208	198	192	176	177	155	126	102	79	93	68	109	90	100	81	73	308	269	252	225	359	304	263	210	248	195	116	251	214	175	165	149	73	39	66	49	52	49	32	42
Cash	56	55	42	34	46	36	47	58	56	86	54	102	49	65	55	62	207	116	67	74	227	180	153	127	205	163	95	230	170	128	111	71	67	31	59	45	48	46	30	16
Cash & Short-Term Investments	203	193	187	171	171	150	122	96	73	86	54	102	84	95	75	64	298	254	243	215	347	291	248	196	233	181	107	230	170	128	111	71	67	31	59	45	48	46	30	16
Receivables	–	–	0.3	0.3	0.3	0.5	0.2	0.2	0.2	–	6.7	1.6	1.7	1.8	2.1	2.9	3.4	9.4	2.6	1.3	1.3	0.0	–	–	–	–	–	7.6	17	8.7	7.4	19	–	4.8	4.4	0.9	0.8	0.4	0.2	25
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	0.0	0.0	–	0.0	–	0.0	–	0.0	0.0	0.0	0.0	–	–	–	–	0.0	–	5.3	19	30	42	53	–	–	–	–	–	–	–	–
Property, Plant & Equipment	35	36	36	35	34	33	31	30	28	26	25	23	21	19	18	16	15	14	14	27	17	36	19	20	19	23	24	134	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	144	140	133	128	126	129	149	146	140	169	177	164	156	181	172	166	168	168	162	169	221	223	239	250	244	338	318	384	383	403	401	409	155	126	114	111	100	94	91	67
Current Liabilities	32	30	27	26	27	32	35	37	39	42	42	43	42	46	44	44	46	46	48	56	95	82	82	89	82	86	64	78	79	99	98	108	65	41	31	31	22	19	19	20
Short-Term Debt	16	7.5	6.8	7.0	6.8	9.2	8.9	11	12	12	8.8	8.9	8.7	4.5	4.6	4.8	5.0	5.6	8.6	12	15	6.6	6.8	7.1	7.3	4.1	4.8	5.5	6.3	5.6	8.8	9.2	8.3	8.7	9.0	9.5	9.9	10	11	12
Accounts Payable	4.2	7.6	5.6	3.9	5.4	7.0	5.4	5.2	6.5	6.4	3.9	4.8	4.5	4.9	5.5	4.2	6.2	4.0	4.9	5.5	8.6	14	6.8	14	10	17	12	13	9.0	3.6	5.2	4.8	8.3	4.1	2.2	2.2	1.7	1.7	2.3	1.2
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	19	–	–	25	25	25	25	25	22	19	16	25	50	51	51	51	51	101	101	102	102	102	–	–	–	–	–	–	–	–
Shareholders' Equity	154	133	111	88	86	61	10	-13	-31	-48	-70	-18	-32	-48	-62	-66	188	175	144	101	176	132	81	23	68	11	-48	23	-15	-45	-60	-87	24	14	50	33	44	44	26	35
Retained Earnings	-149	-174	-200	-228	-235	-264	-318	-346	-368	-389	-414	-424	-441	-460	-480	-500	-531	-549	-584	-633	-564	-614	-671	-736	-796	-865	-936	-889	-937	-978	-1,018	-1,051	-962	-978	-945	-965	-957	-972	-992	-988
Shares Outstanding	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.1	2.3	3.5	3.5	3.5	3.7	4.2	4.6	4.6	4.6	4.7	4.6	4.6	4.6	6.1	6.3	6.3	6.5	6.4	6.5	7.3	7.6	7.6	8.7	8.7	8.7	8.8	8.9	9.6	9.6

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings